Cassava Sciences Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Cassava Sciences, Inc. (SAVA) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents128.57121.14201.02233.4493.5123.0819.81
Cash & Short-Term Investments128.57121.14201.02233.4493.5123.0819.81
Accounts Receivable0.950.960.000.000.000.000.00
Inventory0.000.000.000.000.000.000.00
Other Current Assets7.010.290.160.050.460.270.23
Total Current Assets136.53129.63211.23244.4893.9923.3520.04
Non-Current Assets
Property, Plant & Equipment (Net)20.9621.8522.9920.830.310.050.09
Intangible Assets0.040.180.621.080.000.000.00
Other Non-Current Assets0.000.000.000.400.000.000.01
Total Non-Current Assets21.0022.0323.6122.300.010.050.10
Total Assets157.53151.66234.83266.7894.3023.4020.14
Current Liabilities
Accounts Payable7.6510.574.027.130.911.290.45
Accrued Liabilities4.053.042.282.800.800.000.00
Other Current Liabilities4.100.390.490.630.090.010.00
Total Current Liabilities11.7514.207.0612.531.871.390.51
Non-Current Liabilities
Long-Term Debt0.000.000.040.140.240.000.00
Other Non-Current Liabilities0.083.040.200.190.000.000.00
Total Non-Current Liabilities0.083.040.230.330.240.000.00
Total Liabilities11.8314.207.3012.872.101.390.51
Stockholders' Equity
Common Stock0.050.040.040.040.040.000.00
Retained Earnings-405.11-380.77-283.55-207.31-174.92-168.59-163.96
Additional Paid-in Capital550.77518.20511.05461.18267.09190.66183.57
Shares Outstanding48.2042.2441.7440.020.000.000.00
Total Stockholders' Equity145.70137.47227.54253.9292.2022.1019.63
Total Liabilities & Equity157.53151.66234.83266.7894.3023.4020.14